Prevest Denpro Ltd.
Fundamentals
- Market cap
- ₹454 cr
- P/E
- 22.17×
- ROE
- 17.20%
- Debt / equity
- 0.00
- 52-week range
- 318.15 — 622.05
Analysis — the numbers vs the call
- Prevest Denpro's credibility gap: 3D printer launch date shifted 19 months without explanation
CEO claimed in June 2026 sales began Nov 2024, but had said in May 2025 the printer was not yet commercial. The contradiction muddies a solid annual result.
Company snapshot
Prevest Denpro Ltd.
Pharmaceuticals
₹477 cr
P/E 23.26×
Latest quarter · Mar 2026
Sales₹19 cr
Net profit₹6 cr
Op. margin+36.5%
EPS₹4.85
Strength & growth
Debt / equity0.00×
Current ratio14.38×